Temporal and quantitative pharmacoproteomics approach in the identification of efficacy biomarkers: the example of the natural medicinal product γ-Tocotrienol on prostate cancer
- 作者L. Loizou; T. Roumeliotis; A. Evdokiou; P. Vraka; S. Garbis; A. Odysseos
- 卷第25卷
- 印刷ISSN1871-6784
- 文件大小62.34KB
- 发表时间2009
- DOI10.1016/j.nbt.2009.06.043
A global protein–lipid interactome mapBrehme, Marc; Vidal, Marc · Molecular Systems Biology · 2010
Handbook of Systems Biology || ReviewersBrehme, Marc · 2013
A Chaperome Subnetwork Safeguards Proteostasis in Aging and Neurodegenerative DiseaseBrehme, Marc; Voisine, Cindy; Rolland, Thomas; Wachi, Shinichiro; Soper, James H.; Zhu, Yitan; Orton, Kai; Villella, Adriana; Garza, Dan; Vidal, Marc; Ge, Hui; Morimoto, Richard I. · Cell Reports · 2014
Proteostasis Network Deregulation Signatures as Biomarkers for Pharmacological Disease InterventionBrehme, Marc; Sverchkova, Angelina; Voisine, Cindy · Current Opinion in Systems Biology · 2019
Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicityBrehme, Marc; Voisine, Cindy · Disease Models & Mechanisms · 2016
Local Intra-Arterial Drug Delivery for Prevention of RestenosisTEPE, GUNNAR; DUDA, STEPHAN H.; KALINOWSKI, MARC; KAMENZ, JOACHIM; BREHME, UTE; HANKE, HARTMUT; CLAUSSEN, CLAUS D.; BARES, ROLAND; BAUMBACH, ANDREAS; DINKELBORG, LUDGER M. · Investigative Radiology · 2001
A systematic atlas of chaperome deregulation topologies across the human cancer landscapeHadizadeh Esfahani, Ali; Sverchkova, Angelina; Saez-Rodriguez, Julio; Schuppert, Andreas A.; Brehme, Marc; Wang, Edwin · PLOS Computational Biology · 2018